Prof. Dr. Christof Hettich

Prof Dr. Hettich is a lawyer and partner at RITTERSHAUS Rechtsanwälte in Mannheim, Germany and is specializing the fields of Mergers & Acquisitions, the structuring and restructuring of companies as well as general corporate law. He is also a co-founder and managing director of dievini Hopp BioTech holding GmbH & Co. KG. For many years he has been on boards of private and publicly traded companies in different industry sectors. Dr. Hettich is currently also the Chief Executive Officer of SRH Holding as well as an honorary professor at the Hochschule Heidelberg. He was for many years also an assistant lecturer at the University of Heidelberg (LL.M. coporate restructuring). He studied law and political science at the Universities of Freiburg, Würzburg and Mannheim, Germany and received his Ph.D. from the University of Würzburg, Germany.

Dr. Jennifer Fischer

Dr. Jennifer Fischer is a member of the Advisory Board of HI-STEM gGmbH. She currently serves as Program Officer at the Dietmar Hopp Stiftung, where she supports strategic initiatives in biomedical research and innovation. With a scientific background and previous research experience at Heidelberg University Hospital, Dr. Fischer contributes valuable expertise in translational science and research funding to support the advancement of stem cell research and its clinical applications.

Prof. Dr. Michael Baumann

Since November 2016, Prof. Dr. Michael Baumann is chairman and scientific member of the board of directors of the German Cancer Research Center.

Prof. Baumann is a specialist in radiooncology. Before taking his position at the DKFZ, he was Chair of the Department of Radiation Oncology at the University Hospital Carl Gustav Carus, director at the Institute for Radiooncology at the Helmholtz Center Dresden-Rossendorf, as well as director of the OncoRay Center. Furthermore, he was the founding director of the University Cancer Center Dresden and spokesperson of the DKTK and NCT partner site Dresden. His research focuses on translational-orientated experimental radiotherapy and radiobiology, as well as the treatment of lung and head and neck cancer.

More information: www.dkfz.de/en/dkfz/struktur/vorstand.html

Ursula Weyrich

Since January 2020, Ursula Weyrich acts as Administrative Director of DKFZ. Before joining the DKFZ, she held executive position at the German Center for Neurodegenerative Diseases, the GSI Helmholtz Centre for Heavy Ion Research and the Facility for Antiproton and Ion Research in Europe (FAIR) GmbH in Darmstadt and at the German Federal Ministry for Education and Research (BMBF).

More information: www.dkfz.de/en/dkfz/struktur/vorstand.html